Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrin Spiegel

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
European Journal of Pharmacology|October 22, 2008
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinibElizabeth Day, Beatrice Waters, Katrin Spiegel, et al.
Structure (London, England : 1993)|February 16, 2008
Solution NMR structure of a designed metalloprotein and complementary molecular dynamics refinementJennifer R Calhoun, Weixia Liu, Katrin Spiegel, et al.
CNS Drugs|March 7, 2025
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's DiseaseYigal Paul Goldberg, Leehee Navon-Perry, Andrés Cruz-Herranz, et al.
Journal of Chemical Information and Modeling|March 28, 2015
FOCUS--Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal ChemistsNikolaus Stiefl, Peter Gedeck, Donovan Chin, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
European Journal of Pharmacology|October 22, 2008
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinibElizabeth Day, Beatrice Waters, Katrin Spiegel, et al.
Structure (London, England : 1993)|February 16, 2008
Solution NMR structure of a designed metalloprotein and complementary molecular dynamics refinementJennifer R Calhoun, Weixia Liu, Katrin Spiegel, et al.
CNS Drugs|March 7, 2025
The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's DiseaseYigal Paul Goldberg, Leehee Navon-Perry, Andrés Cruz-Herranz, et al.
Journal of Chemical Information and Modeling|March 28, 2015
FOCUS--Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal ChemistsNikolaus Stiefl, Peter Gedeck, Donovan Chin, et al.
Pageof 2